We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04309409
Brief Title: Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma (NivoMela)

First Submitted : March 12, 2020
First Submitted that Met QC Criteria : March 12, 2020
First Posted : March 16, 2020

Last Update Submitted that Met QC Criteria : November 1, 2022
Last Update Posted : November 2, 2022